Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

Objectives: To determine the efficacy of commonly used medications in comparison with placebo or no treatment for the prevention of renal stone recurrence (metaphylaxis) as documented in the literature. Methods: A MEDLINE search identified 14 randomized, controlled trials comprising 20 treatment arms and 6 different drug therapies for the prevention of stone recurrence. The active treatment arms from each of the trials were combined, and the results were compared with those of the control or no treatment arms overall and for each category of drug therapy (thiazide diuretics, allopurinol, phosphate, magnesium, and alkali citrate). A meta-analysis was performed of the combined treatment and control arms for all trials from which sufficient data were provided, both for overall medical therapy and for thiazide treatment. Results: A statistically significant benefit of drug therapy for stone metaphylaxis was identified (P = 0.04), largely because of the benefit of thiazides compared with placebo or no treatment (P = 0.02). Allopurinol conferred no overall benefit, although the only trial evaluating therapy in hyperuricosuric patients showed a statistically significant benefit. Conclusion: Medical therapy for calcium stone disease reduces the incidence of recurrence. Although only thiazide diuretics among the drug therapies were shown to significantly reduce stone recurrence, variability in study design and study population precluded adequate analysis of other drug therapies such as alkali citrate. Standardization of study design and reporting should improve the evaluation of the efficacy of new drug treatments.

Original languageEnglish (US)
Pages (from-to)679-685
Number of pages7
JournalJournal of Endourology
Volume13
Issue number9
StatePublished - 1999

Fingerprint

Meta-Analysis
Drug Therapy
Therapeutics
Thiazides
Sodium Chloride Symporter Inhibitors
Recurrence
Allopurinol
Alkalies
Calcium Oxalate Nephrolithiasis
Placebos
MEDLINE
Citric Acid
Randomized Controlled Trials
Phosphates
Calcium
Kidney
Incidence

ASJC Scopus subject areas

  • Urology

Cite this

@article{7e32624a059948a3b890c52a54f7cd7a,
title = "Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis",
abstract = "Objectives: To determine the efficacy of commonly used medications in comparison with placebo or no treatment for the prevention of renal stone recurrence (metaphylaxis) as documented in the literature. Methods: A MEDLINE search identified 14 randomized, controlled trials comprising 20 treatment arms and 6 different drug therapies for the prevention of stone recurrence. The active treatment arms from each of the trials were combined, and the results were compared with those of the control or no treatment arms overall and for each category of drug therapy (thiazide diuretics, allopurinol, phosphate, magnesium, and alkali citrate). A meta-analysis was performed of the combined treatment and control arms for all trials from which sufficient data were provided, both for overall medical therapy and for thiazide treatment. Results: A statistically significant benefit of drug therapy for stone metaphylaxis was identified (P = 0.04), largely because of the benefit of thiazides compared with placebo or no treatment (P = 0.02). Allopurinol conferred no overall benefit, although the only trial evaluating therapy in hyperuricosuric patients showed a statistically significant benefit. Conclusion: Medical therapy for calcium stone disease reduces the incidence of recurrence. Although only thiazide diuretics among the drug therapies were shown to significantly reduce stone recurrence, variability in study design and study population precluded adequate analysis of other drug therapies such as alkali citrate. Standardization of study design and reporting should improve the evaluation of the efficacy of new drug treatments.",
author = "Pearle, {Margaret S} and Claus Roehrborn and Pak, {Charles Y}",
year = "1999",
language = "English (US)",
volume = "13",
pages = "679--685",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis

AU - Pearle, Margaret S

AU - Roehrborn, Claus

AU - Pak, Charles Y

PY - 1999

Y1 - 1999

N2 - Objectives: To determine the efficacy of commonly used medications in comparison with placebo or no treatment for the prevention of renal stone recurrence (metaphylaxis) as documented in the literature. Methods: A MEDLINE search identified 14 randomized, controlled trials comprising 20 treatment arms and 6 different drug therapies for the prevention of stone recurrence. The active treatment arms from each of the trials were combined, and the results were compared with those of the control or no treatment arms overall and for each category of drug therapy (thiazide diuretics, allopurinol, phosphate, magnesium, and alkali citrate). A meta-analysis was performed of the combined treatment and control arms for all trials from which sufficient data were provided, both for overall medical therapy and for thiazide treatment. Results: A statistically significant benefit of drug therapy for stone metaphylaxis was identified (P = 0.04), largely because of the benefit of thiazides compared with placebo or no treatment (P = 0.02). Allopurinol conferred no overall benefit, although the only trial evaluating therapy in hyperuricosuric patients showed a statistically significant benefit. Conclusion: Medical therapy for calcium stone disease reduces the incidence of recurrence. Although only thiazide diuretics among the drug therapies were shown to significantly reduce stone recurrence, variability in study design and study population precluded adequate analysis of other drug therapies such as alkali citrate. Standardization of study design and reporting should improve the evaluation of the efficacy of new drug treatments.

AB - Objectives: To determine the efficacy of commonly used medications in comparison with placebo or no treatment for the prevention of renal stone recurrence (metaphylaxis) as documented in the literature. Methods: A MEDLINE search identified 14 randomized, controlled trials comprising 20 treatment arms and 6 different drug therapies for the prevention of stone recurrence. The active treatment arms from each of the trials were combined, and the results were compared with those of the control or no treatment arms overall and for each category of drug therapy (thiazide diuretics, allopurinol, phosphate, magnesium, and alkali citrate). A meta-analysis was performed of the combined treatment and control arms for all trials from which sufficient data were provided, both for overall medical therapy and for thiazide treatment. Results: A statistically significant benefit of drug therapy for stone metaphylaxis was identified (P = 0.04), largely because of the benefit of thiazides compared with placebo or no treatment (P = 0.02). Allopurinol conferred no overall benefit, although the only trial evaluating therapy in hyperuricosuric patients showed a statistically significant benefit. Conclusion: Medical therapy for calcium stone disease reduces the incidence of recurrence. Although only thiazide diuretics among the drug therapies were shown to significantly reduce stone recurrence, variability in study design and study population precluded adequate analysis of other drug therapies such as alkali citrate. Standardization of study design and reporting should improve the evaluation of the efficacy of new drug treatments.

UR - http://www.scopus.com/inward/record.url?scp=0032801371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032801371&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 679

EP - 685

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 9

ER -